We are live on
!
Find out more
Marshall Wace Portfolio holdings
AUM
$100B
1-Year Est. Return
35.1%
This Fund
S&P 500
This Quarter
Est. Return
+22.23%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$18.5B
AUM Growth
+$2.83B
(+18%)
Cap. Flow
+$342M
Cap. Flow
% of AUM
1.85%
Top 10 Holdings %
Top 10 Hldgs %
16.55%
Holding
2,427
New
891
Increased
366
Reduced
546
Closed
599
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Thermo Fisher Scientific
TMO
|
+$163M |
| 2 |
Carnival Corporation Ltd
CCL
|
+$137M |
| 3 |
Repligen
RGEN
|
+$104M |
| 4 |
Biogen
BIIB
|
+$104M |
| 5 |
Zoetis
ZTS
|
+$91.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$173M |
| 2 |
Agilent Technologies
A
|
+$137M |
| 3 |
Fidelity National Information Services
FIS
|
+$86.2M |
| 4 |
Adobe
ADBE
|
+$76.2M |
| 5 |
Keurig Dr Pepper
KDP
|
+$75.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 28.24% |
| 2 | Consumer Discretionary | 12.89% |
| 3 | Financials | 10.77% |
| 4 | Technology | 9.62% |
| 5 | Industrials | 4.73% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1126
Allstate
ALL
$69.3B
| $1.24M | 0.01% |
+11,248
| New | +$1.11M |
|
1127
Keros Therapeutics
KROS
$197M
| $1.23M | 0.01% |
+17,492
| New | +$1.1M |
|
1128
Li Auto
LI
$13.9B
| $1.23M | 0.01% |
42,648
+31,759
| +292% | +$871K |
|
|
NSCO.WS
1129
CALL
DELISTED
Nesco Holdings, Inc. Warrants, exerciseable for Common Stock
NSCO.WS
| $1.23M | 0.01% |
+166,665
| New | +$82.1K |
|
|
AAT
1130
American Assets Trust
AAT
$1.49B
| $1.22M | 0.01% |
42,263
-122,938
| -74% | -$3.27M |
|
1131
Establishment Labs
ESTA
$2.76B
| $1.22M | 0.01% |
32,442
-31,425
| -49% | -$828K |
|
1132
Braskem
BAK
$956M
| $1.22M | 0.01% |
+135,202
| New | +$1.15M |
|
1133
National Beverage
FIZZ
$3.04B
| $1.22M | 0.01% |
28,676
-95,000
| -77% | -$4.09M |
|
1134
Alector
ALEC
$170M
| $1.22M | 0.01% |
80,371
-51,047
| -39% | -$634K |
|
|
FLG
1135
Flagstar Bank National Association
FLG
$5.76B
| $1.2M | 0.01% |
38,037
-14,845
| -28% | -$410K |
|
1136
AudioCodes
AUDC
$249M
| $1.2M | 0.01% |
43,583
+6,600
| +18% | +$194K |
|
|
HOLX
1137
DELISTED
Hologic
HOLX
| $1.2M | 0.01% |
16,479
-681,623
| -98% | -$48.1M |
|
|
YQ
1138
17 Education & Technology Group
YQ
$20.8M
| $1.2M | 0.01% |
+4,677
| New | +$1.35M |
|
1139
Armstrong World Industries
AWI
$7.76B
| $1.2M | 0.01% |
16,093
-32,442
| -67% | -$2.35M |
|
1140
Boston Omaha
BOC
$438M
| $1.19M | 0.01% |
43,049
-90,137
| -68% | -$1.84M |
|
1141
Gartner
IT
$10.6B
| $1.18M | 0.01% |
7,389
+5,776
| +358% | +$832K |
|
|
SRDX
1142
DELISTED
Surmodics
SRDX
| $1.18M | 0.01% |
27,202
-8,741
| -24% | -$344K |
|
1143
Steel Dynamics
STLD
$37.2B
| $1.18M | 0.01% |
+31,913
| New | +$1.11M |
|
|
ARCH
1144
DELISTED
Arch Resources, Inc.
ARCH
| $1.18M | 0.01% |
+26,884
| New | +$1M |
|
1145
ARK Genomic Revolution ETF
ARKG
$1.54B
| $1.18M | 0.01% |
+12,600
| New | +$1M |
|
|
CCRD
1146
DELISTED
CoreCard
CCRD
| $1.17M | 0.01% |
29,263
-2,204
| -7% | -$86.9K |
|
|
NPKI
1147
NPK International
NPKI
$1.1B
| $1.17M | 0.01% |
611,000
-98,113
| -14% | -$132K |
|
|
NVO
1148
Novo Nordisk
NVO
$226B
| $1.16M | 0.01% |
33,246
-61,236
| -65% | -$2.12M |
|
1149
Futu Holdings
FUTU
$14.2B
| $1.16M | 0.01% |
+25,345
| New | +$954K |
|
|
NXRT
1150
NexPoint Residential Trust
NXRT
$689M
| $1.15M | 0.01% |
+27,239
| New | +$1.19M |
|
Similar funds
Marshall Wace's Q4 2020 Portfolio in Review
As of Q4 2020, Marshall Wace held 2,427 positions worth $18.5B, up 18% from $15.6B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Marshall Wace's Q4 2020 filing shows 891 new, 366 increased, 546 reduced and 599 closed positions. Its largest new stake was Natera: 911,254 shares worth $90.7M. The largest sale was Alphabet (Google) Class A, an estimated $173M.
By sector, the portfolio is most concentrated in Healthcare at 28% of assets, up from 24% a quarter earlier, followed by Consumer Discretionary and Financials.
- Marshall Wace's largest Q4 2020 buy was Natera: 911,254 shares worth $90.7M.
- Marshall Wace added most to Thermo Fisher Scientific in Q4 2020, an estimated $163M increase.
- Marshall Wace's biggest Q4 2020 reduction was Alphabet (Google) Class A, cutting an estimated $173M.
- Marshall Wace fully exited FedEx in Q4 2020, selling an estimated $69.6M.
- Marshall Wace's ten largest holdings make up 17% of its $18.5B portfolio in Q4 2020.
- Marshall Wace opened 891 new positions and closed 599 in Q4 2020.
- Marshall Wace's portfolio value rose 18% quarter-over-quarter to $18.5B.
Based on Marshall Wace's 13F filing for Q4 2020, filed 16 Feb 2021.